Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.10.2022 | Case report

Lanreotide

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ryzhkova D, et al. Dual-tracer PET/CT imaging to determine tumor heterogeneity in a patient with metastatic ACTH-secreting neuroendocrine neoplasm: A case report and literature review. [Review]. Frontiers in Endocrinology 13: 958442, Jan 2022. Available from: URL: http://doi.org/10.3389/fendo.2022.958442 Ryzhkova D, et al. Dual-tracer PET/CT imaging to determine tumor heterogeneity in a patient with metastatic ACTH-secreting neuroendocrine neoplasm: A case report and literature review. [Review]. Frontiers in Endocrinology 13: 958442, Jan 2022. Available from: URL: http://​doi.​org/​10.​3389/​fendo.​2022.​958442
Metadaten
Titel
Lanreotide
Lack of efficacy: case report
Publikationsdatum
01.10.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-25483-4

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Sunitinib

Case report

Antineoplastics